Plain-words guide

How cancer stage and biomarkers decide which treatments may apply

How cancer stage (TNM) and biomarkers like HER2 or EGFR change which treatments may apply, including targeted therapy, explained in plain words.

How stage and biomarkers work together (see the staging guide)

Two things in your reports shape which treatments may apply. Stage describes how far the cancer has grown or spread. Biomarkers are measurable signs in the body or in the tumour, such as a protein level or a gene change.

Doctors consider stage and markers together, because both shape the choice of treatment. The type of cancer and the person's general health matter too, so the picture varies a lot from person to person. Stage is explained in more detail in our staging guide.

Your oncologist decides which treatments may apply. Your oncologist explains what this means for you and how the options fit together.

What biomarkers add

Biomarkers describe features of the tumour itself. Some are looked for on the biopsy sample, and some are found by other laboratory tests. For targeted therapy, doctors look for markers that a particular medicine is designed to act on.

If a marker has not been tested, the report may not show whether a targeted option exists. If a pathology report does not mention a marker, the test may not have been done, or the result may be in a separate report. In that case, it is reasonable to ask your oncologist whether more testing is needed.

Targeted therapy: when a marker opens a door

Targeted therapy is a kind of cancer medicine that acts on a specific feature of cancer cells, such as a protein or a gene change that helps them grow. It is used only when testing shows the tumour has that feature. If the marker is present, that medicine may be an option. If it is absent, that medicine is usually not used.

Some targeted medicines are tablets, and some are given by injection or drip. Targeted therapy does not replace chemotherapy for every cancer, and the two are sometimes used together or one after the other. It can still cause side effects, such as skin changes, tiredness or an upset stomach. Never stop or change a medicine on your own.

Examples: HER2 in breast cancer, EGFR in lung cancer

These are examples of how a marker result can change which treatments may apply. They are not a full list, and not every cancer has such a feature. The meaning of HER2 results, including positive, negative and low, has its own guide on this website.

In both cancers, whether a targeted medicine is relevant also depends on the stage and the person's health. If you are unsure whether your tumour was tested, ask your oncologist.

  • Breast cancer: HER2 is a protein on the surface of some cancer cells.
  • When a breast tumour has a lot of HER2, certain targeted medicines may be options.
  • Hormone receptors are also checked, and can guide hormone-based treatment.
  • Lung cancer: the tumour is often tested for gene changes such as EGFR and ALK.
  • These lung tests use a biopsy sample, or sometimes a blood sample.

How OncoVOIS matches options to your reports

OncoVOIS reads the reports you add, shows what it found, and lets you check it. Nothing is saved until you confirm. It then looks at your stage and markers, such as HER2 or EGFR, and matches them to a reviewed list of treatments commonly discussed for that situation.

The AI does not invent the matches. Each option is labelled as something to discuss, not a recommendation, and the app says when it is not sure. If a marker is missing, it may show a test that guidelines commonly list, so you can ask whether it has been done.

Your cancer profile gathers stage, markers and treatment so far on one page. The oncologist decides what is suitable.

Frequently asked questions

What is targeted therapy for cancer?

Targeted therapy is a kind of cancer medicine that acts on a specific feature of cancer cells, such as a protein or a gene change that helps them grow. Because it aims at that feature, it works differently from medicines that act on all fast-growing cells.

Targeted therapy is only used when testing shows the tumour has the feature the medicine is aimed at. This is why a person's reports matter: the biopsy and special tests on the tumour sample may show whether such a feature is present. Some targeted medicines are tablets and some are given by injection or drip. Whether targeted therapy is relevant at all depends on the type of cancer, its stage, the test results and the person's general health, so it varies a lot. Your oncologist, the cancer specialist treating you, decides whether it is an option and can explain how it fits with other treatment.

How is targeted therapy different from chemotherapy?

Chemotherapy mainly acts on cells that divide quickly, which includes cancer cells but also some healthy cells. Targeted therapy is designed to act on a particular feature of cancer cells, so it is chosen only when a matching feature has been found in the tumour.

Because of this, the two can have different side effects, and they are sometimes used together or one after the other. Targeted therapy does not replace chemotherapy for every cancer, and chemotherapy is still an important treatment for many cancers. Neither is simply better than the other in general. Which one is used depends on the cancer type, stage, test results and the person's health, and that is a decision for the oncologist. A good question for your next visit is: what is the aim of this treatment, and why was it chosen instead of the other options? OncoVOIS can show both kinds of treatment from a reviewed list, each labelled as something to discuss.

How do biomarkers decide whether targeted therapy may apply?

A biomarker is a measurable sign in the body or in the tumour, such as a protein level or a gene change. For targeted therapy, doctors look for markers that a particular medicine is designed to act on. If the marker is present, that medicine may be an option. If it is absent, that medicine is usually not used.

Some markers are looked for on the biopsy sample, and some are found by other laboratory tests. Stage, which describes how far the cancer has grown or spread, is considered together with the markers, because both shape the choice of treatment. If a marker has not been tested, the report may not show whether a targeted option exists. In that case it is reasonable to ask the oncologist whether more testing is needed. OncoVOIS reads the markers and stage in your reports and shows options that may be worth asking about. Only your oncologist can say what applies to you.

What is targeted therapy for breast cancer?

For breast cancer, doctors often check a marker called HER2, a protein on the surface of some breast cancer cells. When a tumour has a lot of HER2, certain targeted medicines may be options. Hormone receptors, which show whether hormones feed the cancer, are also checked, and these can guide hormone-based treatment.

Not every breast cancer has these features. Whether a targeted medicine is relevant depends on the test results on the tumour sample, the stage and the person's health. The meaning of HER2 results, including positive, negative and low, has its own guide on this website. Your pathology report usually lists these results, and OncoVOIS can explain the words in plain language when you add it. If you are unsure whether your tumour was tested for these markers, ask your oncologist. The app shows treatments to discuss, never a recommendation, and the oncologist decides what is suitable for you.

What is targeted therapy for lung cancer?

In lung cancer, doctors often test the tumour for gene changes such as EGFR and ALK. If one of these is found, a targeted medicine aimed at it may be an option, and some of these medicines are taken as tablets. These tests are usually done on a sample taken during the biopsy, or sometimes on a blood sample.

Not every lung cancer has such a change, and the type of lung cancer, the stage and the person's health all matter. Because the result can change which treatments may apply, many families ask whether the tumour has been tested for these markers. If the pathology report does not mention them, that may mean the test was not done, or it may be in a separate report, so the oncologist is the right person to confirm. OncoVOIS reads what your reports say and lists options to discuss, each labelled as something to talk about with your oncologist rather than advice to follow.

Is there targeted therapy for ovarian cancer?

For some ovarian cancers, yes. Doctors may test for gene changes such as BRCA, and the result can affect which medicines are considered, including a group of targeted medicines. Not every ovarian cancer has such a change, so whether targeted therapy applies depends on the test results.

Testing may be done on the tumour, on a blood sample, or both, and sometimes the result also matters for relatives, which a genetic counsellor can explain. Ovarian cancer treatment usually also involves surgery and chemotherapy, so targeted therapy is often one part of a larger plan, decided by the oncologist. The type of ovarian cancer, the stage and the person's health all play a part. If you do not see a BRCA or similar result in your reports, you can ask your oncologist whether testing has been done or is needed. OncoVOIS can show tests and treatments from a reviewed list to discuss, never as a recommendation.

Is there targeted therapy for colon cancer?

For some colon cancers, yes. Doctors usually test the tumour for gene changes such as RAS and BRAF, and sometimes for other features. These results can decide whether certain targeted medicines may be options and also whether others are unlikely to help.

Because the result can change the options, it is common to ask whether these tests have been done on the tumour sample and where the result appears in the reports. The stage, the part of the colon involved, and the person's general health are also considered. Surgery and chemotherapy remain important parts of treatment for many colon cancers, and targeted therapy is added only in some situations. This varies from person to person, so the oncologist is the right person to explain it. OncoVOIS can read your pathology and laboratory reports, show what they say in plain words, and list options to discuss. It does not recommend a treatment.

Does targeted therapy have side effects?

Yes, it can. Targeted medicines are aimed at specific features of cancer cells, but they can still cause side effects. Which ones appear, and how strong they are, depends on the medicine, the person and the cancer, so there is no single list that fits everyone.

Some side effects are common to several medicines, such as skin changes, tiredness or an upset stomach, while others are specific to one medicine. Your oncologist or pharmacist can tell you what to expect with your own medicine and which signs need a call to the hospital. Never stop or change a medicine on your own. If you develop severe symptoms, such as trouble breathing or a high fever, contact your hospital straight away or call 112, and call 108 for an ambulance, without waiting for the app. OncoVOIS can help you keep a list of questions for the visit, and it can read your summaries aloud, but it does not suggest doses or changes.

How does OncoVOIS find targeted therapy options in my reports?

OncoVOIS reads the reports you add, shows what it found, and lets you check it. Nothing is saved until you confirm. It then looks at your stage and the markers in your reports, such as HER2 or EGFR, and matches them to a reviewed list of treatments commonly discussed for that situation.

The AI does not invent the matches. Each option is labelled as something to discuss with your oncologist, not as a recommendation, and the app says when it is not sure. If a marker is missing from your reports, it may show a test that guidelines commonly list, so you can ask whether it has been done. Your cancer profile gathers stage, markers and treatment so far on one page, each detail showing the report it came from, and you can download it as a PDF or share it with your doctor. You can also type or speak a question in Ask to have a marker explained in plain words. The oncologist decides what is suitable.

This page is general information, not medical advice. OncoVOIS explains and helps you prepare; your oncologist decides about your care.